Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Clasificar por
Keyphrases
Antibody Level
9%
Arbovirus
9%
Attack Rate
27%
Autoimmune Neurological Disorders
100%
Basic Reproduction number R0
9%
Chikungunya Virus (CHIKV)
9%
Colombia
100%
Contaminated Areas
9%
Cranial Nerve Involvement
9%
Cytomegalovirus
9%
Dengue Virus
9%
Disability
18%
Dysautonomia
18%
Encephalitis
9%
Epidemiological Mapping
9%
Epidemiology
9%
Epstein-Barr Virus
9%
Guillain-Barré Syndrome
100%
IgG Antibody
9%
Immunobiology
100%
Infection Rate
9%
Infection Symptoms
9%
Intensive Care Unit Admission
18%
Jejuni
9%
Lag Time
9%
Low Socioeconomic Status
9%
Lumbosacral
9%
Mycoplasma Pneumoniae (M. pneumoniae)
9%
Myelopathy
9%
National Population
9%
Neurological Symptoms
9%
Neurological Syndrome
36%
Nonlinear Interaction
9%
Peripheral Facial Palsy
9%
Population-based Surveillance
9%
Previous Infection
18%
Risk Factors
9%
Santander
9%
Sex-specific
9%
Socioeconomic Status
9%
Specific Attack
9%
Surveillance System
9%
Transverse Myelitis
9%
Zika Outbreak
100%
Zika Virus
36%
Zika Virus Infection
54%
Medicine and Dentistry
Arbovirus
14%
Autoimmunity
100%
Basic Reproduction Number
14%
Case-Control Study
14%
Chikungunya virus
14%
Cohort Effect
14%
Cranial Nerve
14%
Cytomegalovirus
14%
Dengue Virus
14%
Dysautonomia
28%
Encephalitis
14%
Epstein Barr Virus
14%
Facial Nerve Paralysis
14%
Immunoglobulin G
14%
Immunology
100%
Infection
42%
Intensive Care Unit
28%
Neurologic Disease
100%
Socioeconomic Status
28%
Spinal Cord Disease
14%
Surveillance System
14%
Transverse Myelitis
14%
Virus Infection
28%
Zika Fever
57%
Zika virus
100%
Pharmacology, Toxicology and Pharmaceutical Science
Arbovirus
9%
Case-Control Study
9%
Chikungunya virus
9%
Cytomegalovirus
9%
Dengue Virus
9%
Dysautonomia
18%
Encephalitis
9%
Epstein-Barr Virus
9%
Facial Nerve Paralysis
9%
Immunoglobulin G
9%
Infection
27%
Myelitis
9%
Neurologic Disease
100%
Spinal Cord Disease
9%
Syndrome
100%
Virus Infection
18%
Zika Fever
36%
Zika virus
100%